Item 7.01. Regulation FD Disclosure. Ginkgo Bioworks Holdings, Inc. (“Ginkgo”) announced today that it plans to host a presentation and Q&A session reviewing its business performance for the third quarter ended September 30, 2026, on Thursday, November 5, 2026, beginning at 4:30 p.m. ET.…
Filed Oct 29, 2026Accepted Oct 29, 2026, 4:06 PM EDTCIK 1830214Accession 0001628280-26-068220
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
Ginkgo Bioworks Holdings, Inc. (“Ginkgo”) announced today that it plans to host a presentation and Q&A session reviewing its business performance for the third quarter ended September 30, 2026, on Thursday, November 5, 2026, beginning at 4:30 p.m. ET.
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available. To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
Ginkgo announces material information to the public through a variety of means, including filings with the SEC, public conference calls, its website (https://www.ginkgo.bio), its investor relations website (https://investors.ginkgobioworks.com) and its news site (https://investors.ginkgobioworks.com/news). Ginkgo uses these channels, as well as its blog (https://www.ginkgo.bio/resources) and social media accounts on X (@Ginkgo), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) and LinkedIn to communicate with investors and the public about the Company and other matters and encourages investors, the media, and others interested in the Company to review the information it makes public in these locations, as such information could be deemed to be material information.